Drug Profile
LB 71116
Alternative Names: LK 71116Latest Information Update: 22 Aug 2007
Price :
$50
*
At a glance
- Originator LG Chem Investment
- Class Antivirals; Oligopeptides
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 13 May 2003 No development reported - Preclinical for HIV-1 infections in South Korea (unspecified route)
- 07 Jun 2001 Preclinical development for HIV-1 infections in South Korea (Unknown route)
- 02 Sep 1998 No-Development-Reported for HIV-1 infections in South Korea (Unknown route)